Listed

Stryker Corp

SYKNYSECIK 310764HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$6.59bnRevenue, Q2 FY2026, three months to 2026-06-30$6.59bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Jul 31, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$6.59bnRevenue, Q2 FY2026, three months to 2026-06-30$6.59bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Report this figure+9.4% on a year earlier
  • Gross margin68.3%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $4.50bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Revenue: $6.59bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Report this figure+4.5 pts on a year earlier
  • Operating margin25.2%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $1.66bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Revenue: $6.59bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Report this figure+6.7 pts on a year earlier
  • Net margin19.4%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $1.28bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Revenue: $6.59bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Report this figure+4.7 pts on a year earlier
  • Diluted EPS$3.30Diluted EPS, Q2 FY2026, three months to 2026-06-30$3.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Report this figure+44.1% on a year earlier
  • Free cash flow$1.06bnFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $1.26bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0000310764-26-000050. Derived: 6-month figure less the 3-month figure.Capital expenditure: $202.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-31, accession 0000310764-26-000050. Derived: 6-month figure less the 3-month figure.Report this figure+14.1% on a year earlier

Last eight quarters

Full statements
Revenue$6.59bnGross margin 68.3%
Diluted EPS$3.30, Q2 FY2026
Free cash flow$1.06bn, Q2 FY2026
Stryker Corp, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m5,494Revenue, Q3 FY2024, three months to 2024-09-30$5.49bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure6,436Revenue, Q4 FY2024, three months to 2024-12-31$6.44bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure5,866Revenue, Q1 FY2025, three months to 2025-03-31$5.87bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Report this figure6,022Revenue, Q2 FY2025, three months to 2025-06-30$6.02bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Report this figure6,057Revenue, Q3 FY2025, three months to 2025-09-30$6.06bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure7,171Revenue, Q4 FY2025, three months to 2025-12-31$7.17bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure6,020Revenue, Q1 FY2026, three months to 2026-03-31$6.02bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Report this figure6,589Revenue, Q2 FY2026, three months to 2026-06-30$6.59bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Report this figure
Gross margin%64.0%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $3.52bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $5.49bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure64.9%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $4.17bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $6.44bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure63.8%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $3.74bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Revenue: $5.87bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Report this figure63.8%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $3.84bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Revenue: $6.02bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Report this figure63.6%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $3.85bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $6.06bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure64.5%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $4.63bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $7.17bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure63.3%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $3.81bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Revenue: $6.02bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Report this figure68.3%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $4.50bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Revenue: $6.59bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Report this figure
Operating margin%19.7%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $1.08bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-31, accession 0000310764-25-000129.Revenue: $5.49bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure9.0%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $581.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-11, accession 0000310764-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $6.44bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure14.3%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $837.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Revenue: $5.87bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Report this figure18.5%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $1.11bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Revenue: $6.02bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Report this figure18.7%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $1.14bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-31, accession 0000310764-25-000129.Revenue: $6.06bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure25.2%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $1.80bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-11, accession 0000310764-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $7.17bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure15.5%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $936.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Revenue: $6.02bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Report this figure25.2%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $1.66bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Revenue: $6.59bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Report this figure
Net margin%15.2%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $834.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $5.49bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure8.5%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $546.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $6.44bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure11.1%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $654.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Revenue: $5.87bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Report this figure14.7%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $884.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Revenue: $6.02bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Report this figure14.2%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $859.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $6.06bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure11.8%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $849.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $7.17bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure12.4%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $745.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Revenue: $6.02bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Report this figure19.4%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $1.28bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Revenue: $6.59bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Report this figure
Diluted EPS$ per share2.16Diluted EPS, Q3 FY2024, three months to 2024-09-30$2.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure1.41Diluted EPS, Q4 FY2024, three months to 2024-12-31$1.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure1.69Diluted EPS, Q1 FY2025, three months to 2025-03-31$1.69 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Report this figure2.29Diluted EPS, Q2 FY2025, three months to 2025-06-30$2.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Report this figure2.22Diluted EPS, Q3 FY2025, three months to 2025-09-30$2.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure2.20Diluted EPS, Q4 FY2025, three months to 2025-12-31$2.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure1.93Diluted EPS, Q1 FY2026, three months to 2026-03-31$1.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Report this figure3.30Diluted EPS, Q2 FY2026, three months to 2026-06-30$3.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0000310764-26-000050.Report this figure
Free cash flow$m1,304Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $1.47bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-31, accession 0000310764-25-000129. Derived: 9-month figure less the 6-month figure.Capital expenditure: $170.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-31, accession 0000310764-25-000129. Derived: 9-month figure less the 6-month figure.Report this figure1,665Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $1.93bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-11, accession 0000310764-26-000010. Derived: 12-month figure less the 9-month figure.Capital expenditure: $266.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-11, accession 0000310764-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure127Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $250.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Capital expenditure: $123.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Report this figure928Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $1.11bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0000310764-26-000050. Derived: 6-month figure less the 3-month figure.Capital expenditure: $183.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-31, accession 0000310764-26-000050. Derived: 6-month figure less the 3-month figure.Report this figure1,353Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $1.54bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-31, accession 0000310764-25-000129. Derived: 9-month figure less the 6-month figure.Capital expenditure: $187.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-31, accession 0000310764-25-000129. Derived: 9-month figure less the 6-month figure.Report this figure1,875Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $2.14bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-11, accession 0000310764-26-000010. Derived: 12-month figure less the 9-month figure.Capital expenditure: $268.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-11, accession 0000310764-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure415Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $581.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Capital expenditure: $166.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0000310764-26-000031.Report this figure1,059Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $1.26bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0000310764-26-000050. Derived: 6-month figure less the 3-month figure.Capital expenditure: $202.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-31, accession 0000310764-26-000050. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$25.12bnGross margin 64.0%
Diluted EPS$8.40, FY2025
Free cash flow$4.28bn, FY2025
Stryker Corp, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$bn17.1Revenue, FY2021, twelve months to 2021-12-31$17.11bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-14, accession 0000310764-24-000024.Report this figure18.4Revenue, FY2022, twelve months to 2022-12-31$18.45bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-12, accession 0000310764-25-000023.Report this figure20.5Revenue, FY2023, twelve months to 2023-12-31$20.50bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure22.6Revenue, FY2024, twelve months to 2024-12-31$22.59bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure25.1Revenue, FY2025, twelve months to 2025-12-31$25.12bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure
Gross margin%64.1%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $10.97bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-14, accession 0000310764-24-000024.Revenue: $17.11bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-14, accession 0000310764-24-000024.Report this figure62.8%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $11.58bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-12, accession 0000310764-25-000023.Revenue: $18.45bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-12, accession 0000310764-25-000023.Report this figure63.7%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $13.06bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $20.50bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure63.9%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $14.44bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $22.59bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure64.0%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $16.07bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $25.12bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure
Operating margin%15.1%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $2.58bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-14, accession 0000310764-24-000024.Revenue: $17.11bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-14, accession 0000310764-24-000024.Report this figure15.4%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $2.84bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-12, accession 0000310764-25-000023.Revenue: $18.45bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-12, accession 0000310764-25-000023.Report this figure19.0%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $3.89bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $20.50bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure16.3%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $3.69bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $22.59bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure19.5%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $4.89bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $25.12bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure
Net margin%11.7%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $1.99bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-14, accession 0000310764-24-000024.Revenue: $17.11bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-14, accession 0000310764-24-000024.Report this figure12.8%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $2.36bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-12, accession 0000310764-25-000023.Revenue: $18.45bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-12, accession 0000310764-25-000023.Report this figure15.4%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $3.17bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $20.50bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure13.2%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $2.99bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $22.59bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure12.9%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $3.25bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-11, accession 0000310764-26-000010.Revenue: $25.12bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure
Diluted EPS$ per share5.21Diluted EPS, FY2021, twelve months to 2021-12-31$5.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-14, accession 0000310764-24-000024.Report this figure6.17Diluted EPS, FY2022, twelve months to 2022-12-31$6.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-12, accession 0000310764-25-000023.Report this figure8.25Diluted EPS, FY2023, twelve months to 2023-12-31$8.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure7.76Diluted EPS, FY2024, twelve months to 2024-12-31$7.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure8.40Diluted EPS, FY2025, twelve months to 2025-12-31$8.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure
Free cash flow$bn2.7Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $3.26bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-14, accession 0000310764-24-000024.Capital expenditure: $525.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-14, accession 0000310764-24-000024.Report this figure2.0Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $2.62bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-12, accession 0000310764-25-000023.Capital expenditure: $588.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-12, accession 0000310764-25-000023.Report this figure3.1Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $3.71bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-11, accession 0000310764-26-000010.Capital expenditure: $575.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure3.5Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $4.24bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-11, accession 0000310764-26-000010.Capital expenditure: $755.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure4.3Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $5.04bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-11, accession 0000310764-26-000010.Capital expenditure: $761.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-11, accession 0000310764-26-000010.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Stryker Corp
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$8.63bn27,414,742Reduced−187,307
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$7.10bn22,536,843Added+153,662
JPMORGAN CHASE & CO2026-06-30$5.71bn17,260,943Added+1,664,046
STATE STREET CORP2026-06-30$4.90bn15,532,565Added+183,400
GREENLEAF TRUST2026-06-30$4.79bn15,228,545Reduced−709,525
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$2.57bn8,173,167Reduced−161,077
WELLINGTON MANAGEMENT GROUP LLP2026-06-30$2.57bn8,167,185Added+45,478
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$2.45bn7,819,802Added+71,508
MORGAN STANLEY2026-06-30$1.88bn5,960,732Reduced−336,823
ALLIANCEBERNSTEIN L.P.2026-06-30$1.62bn4,927,021Reduced−1,125,968

Recent filings

All 2,290 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Stryker Corp, recent filings
FiledFormWhat it isAccession number
2026-10-3011:08 ET10-QQuarterly reportPeriod 2026-09-300000310764-26-000061
2026-10-2916:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000310764-26-000059
2026-10-0608:08 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-414956
2026-07-3111:41 ET10-QQuarterly reportPeriod 2026-06-300000310764-26-000050
2026-07-3016:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000310764-26-000048
2026-06-2615:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000310764-26-000041
2026-05-2016:21 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-26-232643
2026-05-1111:10 ET10-QQuarterly reportPeriod 2026-03-310000310764-26-000031
2026-05-0813:02 ET8-K5.07 Shareholder vote results0000310764-26-000029
2026-04-3016:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000310764-26-000025

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 11, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested.See the target

About the filer

CIK
310764
Tickers
SYK
Exchange
NYSE
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
MI
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 11:14 ET. Listed shows no prices and gives no investment advice.